226950 — OliX Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- KR₩3tn
- KR₩3tn
- KR₩15bn
Brief: OliX Pharmaceuticals Launches New Subsidiary To Develop mRNA Vaccines and Therapeutics
Brief: OliX Pharmaceuticals Announces FDA Clearance Of The IND To Evaluate The Efficacy Of OLX10010 In Phase 2A Clinical Trial For Hypertrophic Scars
Brief: Olix Pharmaceuticals Announces Expansion Of Collaboration With Laboratoires Théa To Develop Sirna Therapeutics For Ophthalmic Diseases
Brief: OliX Pharmaceuticals receives patent
Brief: OliX Pharmaceuticals receives patent